# Cutaneous Adverse Effects of Elexacaftor‐Tezacaftor‐Ivacaftor: A Single Center Cohort Study on Acne Severity in Adults With Cystic Fibrosis

**Authors:** Aaron D. Smith, Catherine E. Lyons, Lindsay Somerville, R. Hal Flowers, Emily Kaplan, Dana Albon

PMC · DOI: 10.1111/jocd.70528 · Journal of Cosmetic Dermatology · 2025-11-17

## Full-text entities

- **Diseases:** Acne (MESH:D000152), Cystic Fibrosis (MESH:D003550)
- **Chemicals:** Tezacaftor (MESH:C000625213), Elexacaftor (MESH:C000629074), Ivacaftor (MESH:C545203)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12621287/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12621287/full.md

---
Source: https://tomesphere.com/paper/PMC12621287